Table 1.
Challenge at GD17-21 | How? | Dams’ plasma AlloP at parturition (ng/ml) | Offspring (male and female) Hippo AlloP (ng/g) | Novel obj recognition (% time with Object) | Reference |
---|---|---|---|---|---|
Control (nothing, vehicle) | Handling, IP Saline, SC oil | 2.2 ± 0.8 | 1.8 ± 0.2 | 53 ± 4% | •Paris and Frye (2011a,b), Paris et al. (2011, under review) |
Psychological (restraint, variable) | Thrice daily | 0.7 ± 0.2* | 1.0 ± 0.4 | 31 ± 9%* | •Paris and Frye (2011a), Paris and Frye (2011b) |
Immune (LPS-dams only, IL-1β) | LPS (30 μg/kg, IP); IL-1β (1 μg/day, IP) | 1.2 ± 0.1* | 1.5 ± 0.6 (IL-1β only) | 27 ± 9%* (IL-1β only) | • Paris et al. (under review) |
Endocrine (finasteride) | 50 mg/kg | 0.5 ± 0.3* | 0.5 ± 0.2* | 22 ± 7%* | •Paris et al. (2011) |
*Indicates significantly different from control group, p < 0.05.